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What strikes most of us when someone says ‘crystal’ is probably a pleasant adjective like beautiful, 
pure or exquisite. Unfortunately, a gout patient is more likely to perceive it as painful, sore, tender or 
aching! Gout, referred to as the urate crystal deposition disease, is a painful inflammatory arthritis 
that can drop the quality of life of affected individuals and restrict them to a wheelchair if not treated 
on time. In fact, gout was described as "the unwalkable disease" way back in the fifth century BC.1
Acute gouty arthritis is characterized by severe pain, redness, tenderness, heat and swelling of the 
affected joint(s), causing restricted joint mobility. Formation of large crystal deposits called "tophi", 
observed in chronic gout, can cause irreparable damage to the joints and lead to joint 
disability. Joints at the extremities of the body (fingers and toes) are commonly affected.
The basic pathophysiological feature of gout is the deposition of monosodium urate crystals in the 
synovial fluid of the joints following longstanding hyperuricemia. Hyperuricemia is described as the 
presence of higher than normal level of serum urate. It results from a compromise in the delicate 
balance between the production and excretion of uric acid in the body, primarily in the liver and 
the kidneys, respectively. Hyperuricemia is an essential although not sufficient parameter for 
gout.2
Hyperuricemia and gout are complex traits. A number of genetic loci and gene-
environment interactions together confer risk to develop these traits. The key environmental 
risk factors that can trigger gout flares include alcohol consumption and a high intake of purine-
rich foods (meat and sea-foods).3
On the other hand, at least 28 genomic loci that potentially contain variants affecting serum 
urate concentration have been identified by genome-wide association studies.4 One such critically 
important region that has been identified is the SLC2A9 locus located on chromosome 4 of the 
human genome. It turns out to be a major locus that strongly influences serum urate 
concentration in the body, which is not surprising given that the SLC2A9 gene encodes a uric 
acid transporter protein.5
Population-specific genetic effects are evident in the case of hyperuricemia and gout.. It is 
interesting and obvious to us that the population we belong to does influence our appearance. 
But, what is more interesting and less obvious is that it also dictates whether or not we are  
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susceptible to certain diseases. The presence/absence of certain genetic variants (single 
nucleotide polymorphisms) in a population predisposes the population to hyperuricemia, and 
hence gout.
Gout is highly prevalent in the New Zealand Māori and Pacific (Polynesian) peoples, and my 
research attempts to understand the reason for this increased prevalence. My research therefore 
focuses on the identification of population-specific genetic variants within the SLC2A9 locus that 
are associated with hyperuricemia specifically in the Polynesian people.
This research will of course provide a greater insight into the genetic causes of gout but, 
more importantly, the identification of penetrant variants could be applied in 
precision medicine and public health genomics to improve health outcomes for the target 
population.
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